Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics
Authors:
- 1 December 2010
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 9 (12) , 3126-3136
Abstract
Chemoresistance to many commercially available cancer therapeutic drugs is a common occurrence and contributes to cancer mortality as it often leads to disease progression. There have been a number of studies evaluating the mechanisms of resistance and the biological factors involved. microRNAs have recently been identified as playing a role in the regulation of key genes implicated as cancer therapeutic targets or in mechanisms of chemoresistance including EGFR, MDR1, PTEN, Bak1, and PDCD4 among others. This article briefly reviews chemoresistance mechanisms, discusses how microRNAs can play a role in those mechanisms, and summarizes current research involving microRNAs as both regulators of key target genes for chemoresistance and biomarkers for treatment response. It is clear from the accumulating literature that microRNAs can play an important role in chemoresistance and hold much promise for the development of targeted therapies and personalized medicine. This review brings together much of this new research as a starting point for identifying key areas of interest and potentials for future study. Mol Cancer Ther; 9(12); 3126–36. ©2010 AACR.Keywords
This publication has 56 references indexed in Scilit:
- MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant ChemotherapyNeoplasia, 2010
- Implication of microRNAs in drug resistance for designing novel cancer therapyDrug Resistance Updates, 2010
- Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patientsInternational Journal of Hygiene and Environmental Health, 2010
- Expression of MRP1, BCRP, LRP, and ERCC1 in Advanced Non–Small-Cell Lung Cancer: Correlation With Response to Chemotherapy and SurvivalClinical Lung Cancer, 2009
- miRNAs modulate the drug response of tumor cellsScience China Life Sciences, 2009
- Mechanisms of Chemotherapeutic Drug Resistance in Cancer Therapy—A Quick ReviewTaiwanese Journal of Obstetrics and Gynecology, 2009
- Role of microRNA in anticancer drug resistanceInternational Journal of Cancer, 2009
- Gene Polymorphisms and Chemotherapy in Non-small Cell Lung Cancer.2009
- Mechanisms of Cancer Drug ResistanceAnnual Review of Medicine, 2002
- Multidrug resistance (MDR) in cancerEuropean Journal of Pharmaceutical Sciences, 2000